https://www.bankier.pl/wiadomosc/MILESTONE-MEDICAL-Completion-of-clinical-trials-for-its-epidural-instrument-7409749.html
The Company plans to finalize the statistical analysis and otherwise complete its submission of the COMPASS study to FDA in the very near future.